Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
CXCR4 coordinates adhesion, migration, and development of human NK cells
Shira E. Eisman, Francesca E. Grossberg, Batya S. Koenigsberg, David H. McDermott, Frédérique van den Haak, Luis A. Pedroza, Everardo Hegewisch-Solloa, Philip M. Murphy, Emily M. Mace
Shira E. Eisman, Francesca E. Grossberg, Batya S. Koenigsberg, David H. McDermott, Frédérique van den Haak, Luis A. Pedroza, Everardo Hegewisch-Solloa, Philip M. Murphy, Emily M. Mace
View: Text | PDF
Research Article Cell biology Immunology

CXCR4 coordinates adhesion, migration, and development of human NK cells

  • Text
  • PDF
Abstract

Natural killer (NK) cells undergo stepwise differentiation from multipotent progenitors within secondary lymphoid tissues. Despite the central importance of the tissue microenvironment in their development, little is known about cell-cell interactions that regulate human NK cell trafficking and maturation. Here, we identify the chemokine receptor CXCR4 and its ligand CXCL12 as regulators of stromal–NK cell interactions required for NK cell maturation. We demonstrate that CXCR4 is expressed throughout human NK cell development in peripheral blood and tonsil, and CXCL12 is enriched in stromal niches containing developing NK cells. Pharmacologic blockade or genetic disruption of CXCR4 resulted in diminished adhesion to integrin ligands, and high-resolution imaging demonstrated crosstalk between CXCR4 and integrins, providing a mechanistic basis for chemokine-dependent modulation of adhesion. Further, CXCR4 blockade resulted in altered contact-dependent motility on stromal cells and integrin ligands, with decreased stable stromal engagement and increased cell speed. Consistent with a requirement for these interactions, treatment with the CXCR4 antagonist plerixafor (AMD3100) impaired NK cell generation from CD34+ precursors. Analysis of NK cells from patients with WHIM syndrome with CXCR4 gain-of-function mutations treated with plerixafor revealed similar defects in migration and adhesion, supporting the in vivo relevance of CXCR4-dependent regulation of NK cell adhesion and motility.

Authors

Shira E. Eisman, Francesca E. Grossberg, Batya S. Koenigsberg, David H. McDermott, Frédérique van den Haak, Luis A. Pedroza, Everardo Hegewisch-Solloa, Philip M. Murphy, Emily M. Mace

×

Figure 1

CXCR4 is expressed throughout human NK cell development.

Options: View larger image (or click on image) Download as PowerPoint
CXCR4 is expressed throughout human NK cell development.
(A) CXCR4 trans...
(A) CXCR4 transcript in innate lymphoid cell progenitors (ILCPs) and NK subsets from the Human Immune Health Atlas (66). Dot size indicates frequency of CXCR4+ cells; color represents mean expression. (B) NK cell development: CD34+ hematopoietic stem and progenitor cells (HSPCs), CD117+CD94– NK precursors (NKPs), CD94+CD16– NK cells, and CD94+CD16+ NK cells. (C) Extracellular CXCR4 in NK developmental intermediates from tonsil. Gray histogram represents fluorescence minus one (FMO) control. (D) Pooled data from 6 donors corresponding to flow cytometry data in C. n = 6; Friedman test with Dunn’s multiple-comparison correction (paired by donor). Only comparisons with P < 0.05 are displayed. (E) Extracellular CXCR4 mean fluorescence intensity (MFI) in NK developmental intermediates from peripheral blood. (F) Pooled data from 9 donors corresponding to flow cytometry data in E. n = 9; Friedman test with Dunn’s multiple-comparison correction (paired by donor). Only comparisons with P < 0.05 are displayed. (G) Representative histograms of cell surface CXCR4 MFI in primary NK cells (left) and NK92 cell lines (right) after 1-hour treatment with vehicle (solid lines) or 10 μM AMD3100 (dashed lines). Representative of more than 10 biological replicates. (H) Validation of CXCR4 knockout (KO) in NK92 cell line. CXCR4 on WT (solid line) and CRISPR/Cas9 CXCR4-KO (dashed line) cells. Representative of 4 replicates.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts